ClearPoint Neuro Analyst Price Targets

Wall Street analyst price targets and consensus rating for ClearPoint Neuro (CLPT).

Price Target Range — 8 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$25Upside to Avg. PT+125.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 29, 2026	Stifel	Mathew Blackman	PT Cut	Buy	$22→$18
Jun 18, 2026	B. Riley Securities	Anderson Schock	PT Raise	Buy	$20→$30
Mar 18, 2026	B. Riley Securities	Neil Chatterji	PT Raise	Buy	$18→$20
Mar 5, 2026	B. Riley Securities	Neil Chatterji	PT Cut	Buy	$28→$18
Apr 25, 2025	B. Riley Securities	Neil Chatterji	PT Raise	Buy	$20→$28
Apr 1, 2025	Stifel	Mathew Blackman	PT Raise	Buy	$19→$25
Jan 28, 2025	B. Riley Securities	Neil Chatterji	PT Raise	Buy	$15→$20
Jan 21, 2025	Lake Street	Frank Takkinen	PT Raise	Buy	$17→$30
Nov 8, 2024	B. Riley Securities	Neil Chatterji	PT Raise	Buy	$14→$15
Aug 27, 2024	Lake Street	Frank Takkinen	PT Raise	Buy	$11→$15
Mar 13, 2024	Stifel	Mathew Blackman	PT Raise	Buy	$8→$9

Analyst Ratings News

PRO
Stifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $22 to $18.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30

B. Riley Securities analyst Anderson Schock maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $20 to $30.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $18 to $20.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $28 to $18.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $9

Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $8 to $9.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $25

Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $19 to $25.

Benzinga Newsdesk

ClearPoint Neuro Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

ClearPoint Neuro Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Stifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $9

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $25

People Also Watch

People Also Watch

ClearPoint Neuro Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

ClearPoint Neuro Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROStifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

PROB. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30

PROB. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

PROB. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

PROStifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $9

PROStifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $25

People Also Watch

People Also Watch

PRO
Stifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $9

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $25